FDA approves second mRNA boosters for those over 50 and immunocompromised
The U.S. Food and Drug Administration (FDA) announced Tuesday that it has authorized a “second booster dose of either the Pfizer-BioNTech or the Moderna COVID-19 …
FDA approves second mRNA boosters for those over 50 and immunocompromised Read More »